Neoplasia/BPH

	Re: David-Dan Nguyen, Borna Tadayon Najafabadi, Lauren Lin, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005. Eur Urol Shin YS, Kim JH. PMID: 42436089 [PubMed - as supplied by publisher]
	"Cumulative incidence of toxicity between 2 and 5 years following SBRT to the prostate and pelvis nodes in patients with high-risk prostate cancer ". Pract Radiat Oncol Martinez C, Cury F, Duclos M, Tsui JMG, Joseph A, Patrocinio H, Souhami L, Faria S. PMID: 42435987 [PubMed - as supplied by publisher]
	Dosimetric analysis of post-radiotherapy sexual dysfunction in patients receiving definitive stereotactic body radiotherapy (SBRT) for prostate cancer: a secondary analysis of MIRAGE. Radiother Oncol Massachi J, Jiang T, Neilsen BK, Wilhalme H, Ruan D, Casado M, Chong N, Zello L, Lamb JM, Ma TM, Valle LF, Cao M, Steinberg ML, Kishan AU. PMID: 42435817 [PubMed - as supplied by publisher]
	Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol Ito A, Arai Y, Kakehi Y, Yokoyama M, Sasaki K, Uemura M, Takahashi A, Nishimura K, Kawahara T, Masuda H, Yoshimura K, Kobayashi T, Eto M, Igawa T, Nishiyama N, Mochizuki T, Yokomizo A, Miyake M, Ichikawa T, Hashine K, Sato T, Sugimoto M, Nishiyama H, Kitamura H, Urologic Oncology Study Group of the Japan Clinical Oncology Group. PMID: 42435772 [PubMed - as supplied by publisher]
	De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When? Clin Genitourin Cancer Moinard-Butot F, Nannini S, Gravis G, Pautas M, Pignot G, Barthélémy P. PMID: 42435529 [PubMed - as supplied by publisher]
	Relationship Values and Committed Actions Among Couples Coping with Prostate Cancer: A Qualitative Study. Support Care Cancer Ma H, Yang Y, Cariola L, Gillanders D. PMID: 42435221 [PubMed - indexed for MEDLINE]
	(68)Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data. Eur J Nucl Med Mol Imaging Leithner D, Michaud L, Zheng J, Mauguen A, Cheng M, Bedmutha A, Mayerhoefer ME, A Razmaria A, Fine SW, Morris MJ, Imber BS, Zelefsky MJ, Yeh R, Schöder H. PMID: 42435202 [PubMed - as supplied by publisher]
	Metabolic Reprogramming in the Bladder Cancer Microenvironment: Bridging Fundamental Research and Therapeutic Avenues for Cancer-Associated Fibroblasts. Adv Exp Med Biol Silva A, Baltazar F, Afonso J. PMID: 42435169 [PubMed - indexed for MEDLINE]
	Frailty burden and symptomatic BPH/LUTS in aging men: evidence from two nationally representative population-based studies. World J Urol Wu G, Wang J, Shi J, Liu Y, Zheng J, Jiang X, Wang J, Pan L, Tao L. PMID: 42435056 [PubMed - indexed for MEDLINE]
	Tumor enucleation versus conventional partial nephrectomy for localized renal tumors: a systematic review and meta-analysis of functional, perioperative, and margin outcomes. Front Oncol Jiang S, Liu J, Sun L, Zhu Y, Fan Z, Li S, Zhou F. PMID: 42434757 [PubMed]
	From intracellular processing to renal phenotypes: a mechanism-informed framework for interpreting kidney injury and electrolyte patterns with antibody-drug conjugates in solid tumors. Front Pharmacol Jiang Y, Xu J, Wang Z, Zhang S. PMID: 42434135 [PubMed]
	Detecting clinically significant prostate cancer with a distributed parameter model based on quantitative dynamic contrast-enhanced magnetic resonance imaging. Quant Imaging Med Surg Zhang H, Du J, Lei J, Wu K, Hou Z, Lei L, Wang B. PMID: 42433525 [PubMed]
	The value of [(18)F]PSMA-1007 PET/CT combined with mpMRI in diagnosing prostate cancer with PI-RADS 3-4 lesions. Quant Imaging Med Surg Shui R, Li J, Ge S, Cao J, Deng S, Zhang B. PMID: 42433522 [PubMed]
	The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors. Eur Urol Open Sci Iacovelli R, Ciccarese C, Arduini D, Tagliaferri L, Minervini A, Simone G, Ficarra V, Porta C, Calabrò F, Zucali P, Troisi P, Francolini G, Morganti AG, Franzese C, Jereczek-Fossa BA, Maria Rocco BC. PMID: 42433301 [PubMed]
	Histopathological Advantages of En Bloc Resection in Non-muscle-invasive Bladder Cancer: A Multinational Randomised Controlled Clinical Trial. Eur Urol Open Sci Nielsen NK, Milling RV, Hjort PB, Vásquez JL, Haug ES, Sørensen FE, Olsen KØ, Fabrin K, Vjaters E, Rudlang TM, Sepp T, Nurminen P, Geertsen L, Lam GW, Jakobsen JK, Graugaard-Jensen C, Stifter-Vretenar S, Jensen JB, Kingo PS. PMID: 42433300 [PubMed]
	Mental health disorders following nephrectomy for renal cell carcinoma: a national study. BJU Int Esen B, Lahiji R, Patil D, Mumford S, Landrum KR, Nabavizadeh R, Hajiha M, Grajales V, Khater N, Joshi SS, Narayan VM, Ogan K, Master VA. PMID: 42433145 [PubMed - as supplied by publisher]
	Exploring the response shift effects on patient-reported outcomes among postoperative bladder cancer patients: a qualitative study in China. BMC Urol Kang Y, Zhong G, Zhang Y, Chang Z, Wang T, Huang M, Gao R, Li N, Lv A. PMID: 42432550 [PubMed - as supplied by publisher]
	Ultrahypofractionation of localized prostate cancer-an updated statement of the prostate cancer working group of the German Society of Radiation Oncology (DEGRO). Strahlenther Onkol Müller AC, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Höcht S, Hoffmann E, Hölscher T, Koerber SA, Niehoff P, Peeken JC, Pinkawa M, Polat B, Shelan M, Spohn SKB, Wolf F, Zamboglou C, Zips D, Wiegel T. PMID: 42432214 [PubMed - as supplied by publisher]
	Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol He BM, Zhang K, Zhou Z, Chen X, Liu Y, Dong B, Wang Y, Xing Y, He W, Jin Z, Zhang T, Feng T, Liang L, Chen B, Chen S, Lu Z, Zhou S, Zhao Y, Liu Y, Wang Z, Na R, Zhang X, Shi B, Wang HF, IMAGINATION Group. PMID: 42431755 [PubMed - as supplied by publisher]
	Adjuvant penpulimab in very-high risk clear cell renal cell carcinoma: a prospective, non-randomized, controlled phase II trial with integrated plasma multi-omics analyses. J Immunother Cancer Wang Y, Wang D, Zhao H, Zhou Y, Liang Q, Huang Q, Peng C, Xu J, Guo G, Yang G, Chen L, Xun Y, Du J, Ma X, Zhang X, Gu L. PMID: 42431710 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 189637

Page 1 of 9482



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy